{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:29:21Z","timestamp":1786422561923,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.clon.2024.10.005","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T21:52:08Z","timestamp":1728510728000},"page":"103653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Early Outcomes of Preoperative Short Course Radiotherapy With Simultaneous Integrated Boost and Response-adapted Chemotherapy for Advanced Rectal Cancer"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4813-208X","authenticated-orcid":false,"given":"B.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9419-8908","authenticated-orcid":false,"given":"N.S.M.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2478-2645","authenticated-orcid":false,"given":"B.B.W.","family":"Wo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.L.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.clon.2024.10.005_bib1","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with Preoperative radiotherapy in Rectal cancer","volume":"355","author":"Bosset","year":"2006","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.clon.2024.10.005_bib2","series-title":"Centre for Health Protection","year":"2024"},{"issue":"1","key":"10.1016\/j.clon.2024.10.005_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncology"},{"issue":"15","key":"10.1016\/j.clon.2024.10.005_bib4","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1200\/JCO.21.01667","article-title":"Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR)","volume":"40","author":"Jin","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.clon.2024.10.005_bib5","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/annonc\/mdw062","article-title":"Long-course oxaliplatin-based preoperative chemoradiation versus 5 \u00d7 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study","volume":"27","author":"Bujko","year":"2016","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.clon.2024.10.005_bib6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12913-015-0845-9","article-title":"Direct costs of Radiotherapy for rectal cancer: a microcosting study","volume":"15","author":"Hanly","year":"2015","journal-title":"BMC Health Services Reasearch"},{"issue":"1","key":"10.1016\/j.clon.2024.10.005_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijrobp.2012.05.017","article-title":"Radiation dose-response model for locally advanced rectal cancer after pre-operative chemoradiotherapy","volume":"85","author":"Appelt","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clon.2024.10.005_bib8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.clon.2020.06.008","article-title":"Neoadjuvant Radiotherapy Dose Escalation in Locally Advanced Rectal Cancer: a Systematic Review and Meta-analysis of Modern Treatment Approaches and Outcomes","volume":"33","author":"Hearn","year":"2020","journal-title":"Clinical Oncology"},{"issue":"11","key":"10.1016\/j.clon.2024.10.005_bib9","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1111\/cas.15959","article-title":"High-dose rate endorectal brachytherapy for rectal cancer: A state-of-the-art review","volume":"114","author":"Cheng","year":"2023","journal-title":"Cancer Science"},{"issue":"10","key":"10.1016\/j.clon.2024.10.005_bib10","article-title":"Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy Can Benefit the Locally Advanced Rectal Cancer Patients with Clinically Positive Lateral Pelvic Lymph Node","volume":"22","author":"Li","year":"2021","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.clon.2024.10.005_bib11","first-page":"215","article-title":"Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002)","volume":"14","author":"Wang","year":"2019","journal-title":"BMC Radiation Ocnology"},{"issue":"1","key":"10.1016\/j.clon.2024.10.005_bib12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13014-022-02182-4","article-title":"The safety of an MRI simulation-guided boost after short-course preoperative radiotherapy for unresectable rectal cancer (SUNRISE): interim analysis of a randomized phase II trial","volume":"17","author":"Liu","year":"2022","journal-title":"BMC Radiation Oncology"},{"issue":"2","key":"10.1016\/j.clon.2024.10.005_bib13","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1016\/j.ijrobp.2023.06.2369","article-title":"Short Course Radiotherapy (SCRT) with Simultaneous Integrated Boost (SIB) in the Treatment of Rectal Cancer: Feasibility and Early Toxicities","volume":"117","author":"Melton","year":"2023","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"key":"10.1016\/j.clon.2024.10.005_bib14","first-page":"4991","article-title":"Current controversies in TNM for radiological staging of rectal cancer and how to deal with them: results of a global online survery and multidisciplinary expert consensus","volume":"32","author":"Lambregts","year":"2022","journal-title":"Gastrointestinal"},{"issue":"3","key":"10.1016\/j.clon.2024.10.005_bib15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ijrobp.2007.03.046","article-title":"Moderately low alpha\/beta ratio for rectal cancer may best explain the outcome of three fractionation schedules of preoperative radiotherapy","volume":"69","author":"Suwinski","year":"2007","journal-title":"Radiation Oncology Biology Physics"},{"key":"10.1016\/j.clon.2024.10.005_bib16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1259\/bjr\/31372149","article-title":"21 years of Biologically Effective Dose","volume":"83","author":"Flowler","year":"2010","journal-title":"The British Journal of Radiology"},{"issue":"3","key":"10.1016\/j.clon.2024.10.005_bib17","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of Normal Tissue Complication Probability Models In The Clinic","volume":"76","author":"Marks","year":"2010","journal-title":"International Journal of Radiation Oncology Biology\u00a0Physics"},{"issue":"3","key":"10.1016\/j.clon.2024.10.005_bib18","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","article-title":"Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: A Radiation Therapy Oncology Group Consensus Panel Contouring Atlas","volume":"74","author":"Myerson M.D.","year":"2009","journal-title":"International Journal of Radiation Oncolology Biology Physics"},{"issue":"2","key":"10.1016\/j.clon.2024.10.005_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of Surgical Complications","volume":"240","author":"Dindo","year":"2004","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.clon.2024.10.005_bib22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.radonc.2012.12.005","article-title":"Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders: A prospective multicentre study","volume":"106","author":"Bujko","year":"2013","journal-title":"Radiotherapy and Oncology"},{"issue":"S3","key":"10.1016\/j.clon.2024.10.005_bib23","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.annonc.2020.04.096","article-title":"Dose escalated short course radiotherapy in rectal cancers: Is this the way forward?","volume":"31","author":"Chakrabarti","year":"2020","journal-title":"Annals of Oncology"},{"issue":"2","key":"10.1016\/j.clon.2024.10.005_bib24","doi-asserted-by":"crossref","first-page":"O66","DOI":"10.1111\/codi.12466","article-title":"Phase II trial, of short-course radiotherapy followed by delayed surgery for locoregionally advanced rectal cancer","volume":"16","author":"Faria","year":"2014","journal-title":"Colorectal Disease"},{"key":"10.1016\/j.clon.2024.10.005_bib25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/02841860701802585","article-title":"The 'good', the 'bad' and the 'ugly' rectal cancers","volume":"47","author":"Blomqvist","year":"2008","journal-title":"Acta Oncologica"},{"key":"10.1016\/j.clon.2024.10.005_bib26","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.3390\/cancers15112967","article-title":"The Role of MRI and PET\/CT in Radiotherapy Target Volume Determination in Gastrointestinal Cancers\u2014Review of the Literature","volume":"15","author":"Ermen","year":"2023","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.clon.2024.10.005_bib27","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.18632\/oncotarget.6401","article-title":"Dosimetric comparisons of VMAT, IMRT and 3DCRT for locally advanced rectal cancer with simultaneous integrated boost","volume":"7","author":"Jun","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.clon.2024.10.005_bib28","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/jjco\/hyy029","article-title":"Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in rectal cancer treated with neoadjuvant concurrrent chemoradiation: a meta-analysis and pooled-analysis of acuite toxicity","volume":"48","author":"Wee","year":"2018","journal-title":"Japanese Journal of Clinical Oncology"},{"issue":"1","key":"10.1016\/j.clon.2024.10.005_bib29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejso.2017.11.013","article-title":"Management and prognosis of locally recurrent rectal cancer - A national population-based study","volume":"44","author":"Westberg","year":"2018","journal-title":"European Journal of Surgical Oncology (EJSO)"},{"issue":"2","key":"10.1016\/j.clon.2024.10.005_bib30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/SLA.0000000000002528","article-title":"Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer Results From an International Collaboration","volume":"269","author":"Kelly","year":"2019","journal-title":"Annales of Surgery"},{"issue":"4","key":"10.1016\/j.clon.2024.10.005_bib31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.5306\/wjco.v15.i4.472","article-title":"Management of lateral pelvic lymph nodes in rectal cancer: Is it time to reach an Agreement?","volume":"15","author":"Romero-Zoghbi","year":"2024","journal-title":"World Journal of Clinical Oncology"},{"issue":"1","key":"10.1016\/j.clon.2024.10.005_bib32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10147-018-1349-5","article-title":"Diagnostic accuracy of magnetic resonance imaging and computed tomography for lateral lymph node metastasis in rectal cancer: a systematic review and meta-analysis","volume":"24","author":"Hoshino","year":"2019","journal-title":"International Journal of Clinical Oncology"},{"issue":"11","key":"10.1016\/j.clon.2024.10.005_bib33","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.ejso.2021.11.003","article-title":"Lateral lymph node dissection in rectal cancer: State of the art review","volume":"48","author":"Hazen","year":"2022","journal-title":"European Journal of Surgical Oncology"},{"key":"10.1016\/j.clon.2024.10.005_bib34","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3390\/cancers14071643","article-title":"The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes","volume":"14","author":"Meldolesi","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.clon.2024.10.005_bib35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s10350-007-9152-9","article-title":"Extended radical resection: the choice for locally recurrent rectal cancer","volume":"51","author":"Heriot","year":"2008","journal-title":"Diseases of the Colon & Rectum"},{"issue":"13","key":"10.1016\/j.clon.2024.10.005_bib36","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/bjs.10949","article-title":"Prognostic implications of MRI-detected lateral nodal disease and extramural vascular invasion in rectal cancer","volume":"105","author":"Schaap","year":"2018","journal-title":"British Journal of Surgery"},{"issue":"1","key":"10.1016\/j.clon.2024.10.005_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.21037\/jgo.2016.11.03","article-title":"Pathological complete response and disease-free survival are not surrogate endpoints for 5-year survival in rectal cacner: an analysis of 22 randomized trials","volume":"8","author":"Petrelli","year":"2017","journal-title":"Journal of Gastrointestinal Oncology"},{"issue":"8","key":"10.1016\/j.clon.2024.10.005_bib38","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1200\/JCO.23.01196","article-title":"Early Efficacy End Points in Neoadjuvant Rectal Cancer Trials: Surrogacy Revisited","volume":"42","author":"Fokas","year":"2024","journal-title":"Journal of Clinical Oncology"},{"issue":"23","key":"10.1016\/j.clon.2024.10.005_bib39","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy","volume":"40","author":"Garcia-Aguilar","year":"2022","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.clon.2024.10.005_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114044","article-title":"Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial","volume":"204","author":"Zwart","year":"2024","journal-title":"European Journal of Cancer"},{"issue":"9","key":"10.1016\/j.clon.2024.10.005_bib41","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3389\/fonc.2019.00497","article-title":"Predictors and Risk Factors of Pathological Complete Response Following Neoadjuvant Chemoradiatotherapy for Rectal Cancer: A Population-Based Analysis","volume":"13","author":"Tan","year":"2019","journal-title":"Frontiers in Oncology"},{"issue":"4","key":"10.1016\/j.clon.2024.10.005_bib42","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/SLA.0000000000005799","article-title":"Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO Trial","volume":"278","author":"Dijkstra","year":"2023","journal-title":"Annals of Surgery"},{"issue":"6","key":"10.1016\/j.clon.2024.10.005_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2022-065010","article-title":"Towards Response ADAptive Radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial","volume":"13","author":"Verweij","year":"2023","journal-title":"BMJ Open"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655524004187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655524004187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T20:36:11Z","timestamp":1737318971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655524004187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":41,"alternative-id":["S0936655524004187"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2024.10.005","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Outcomes of Preoperative Short Course Radiotherapy With Simultaneous Integrated Boost and Response-adapted Chemotherapy for Advanced Rectal Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2024.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Royal College of Radiologists. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103653"}}